Mesoblast Property Plant Equipment vs Non Current Assets Total Analysis
MESO Stock | USD 18.69 0.13 0.69% |
Mesoblast financial indicator trend analysis is infinitely more than just investigating Mesoblast recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mesoblast is a good investment. Please check the relationship between Mesoblast Property Plant Equipment and its Non Current Assets Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
Property Plant Equipment vs Non Current Assets Total
Property Plant Equipment vs Non Current Assets Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mesoblast Property Plant Equipment account and Non Current Assets Total. At this time, the significance of the direction appears to have no relationship.
The correlation between Mesoblast's Property Plant Equipment and Non Current Assets Total is 0.06. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Mesoblast, assuming nothing else is changed. The correlation between historical values of Mesoblast's Property Plant Equipment and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of Mesoblast are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Property Plant Equipment i.e., Mesoblast's Property Plant Equipment and Non Current Assets Total go up and down completely randomly.
Correlation Coefficient | 0.06 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Property Plant Equipment
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most indicators from Mesoblast's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mesoblast current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.As of the 7th of February 2025, Enterprise Value is likely to grow to about 1.2 B, while Selling General Administrative is likely to drop about 20.5 M.
2022 | 2023 | 2024 | 2025 (projected) | Interest Income | 831K | 1.8M | 2.1M | 2.2M | Reconciled Depreciation | 4.1M | 4.7M | 5.4M | 4.0M |
Mesoblast fundamental ratios Correlations
Click cells to compare fundamentals
Mesoblast Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mesoblast fundamental ratios Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 744.7M | 662.1M | 669.4M | 669.2M | 769.5M | 583.1M | |
Other Current Liab | 18.7M | 2.2M | 5.4M | 49.7M | 57.1M | 60.0M | |
Total Current Liabilities | 94.3M | 51.4M | 42.0M | 73.2M | 84.2M | 88.4M | |
Total Stockholder Equity | 581.4M | 497.0M | 501.8M | 480.4M | 552.4M | 419.6M | |
Property Plant And Equipment Net | 12.1M | 10.0M | 6.5M | 3.8M | 4.4M | 3.6M | |
Net Debt | (31.4M) | 46.9M | 45.6M | 56.4M | 64.8M | 68.1M | |
Retained Earnings | (647.6M) | (738.9M) | (820.8M) | (908.8M) | (817.9M) | (777.0M) | |
Accounts Payable | 19.6M | 23.1M | 20.1M | 7.1M | 8.1M | 15.1M | |
Cash | 136.9M | 60.0M | 70.9M | 62.6M | 71.9M | 67.2M | |
Non Current Assets Total | 596.5M | 592.3M | 587.8M | 582.7M | 670.1M | 466.6M | |
Cash And Short Term Investments | 136.9M | 60.0M | 70.9M | 62.6M | 71.9M | 67.2M | |
Net Receivables | 4.6M | 4.4M | 2.3M | 21.0M | 24.1M | 25.3M | |
Common Stock Shares Outstanding | 605.1M | 682.9M | 839.3M | 986.7M | 1.1B | 1.2B | |
Liabilities And Stockholders Equity | 744.7M | 662.1M | 669.4M | 669.2M | 769.5M | 583.1M | |
Other Current Assets | 7.2M | 5.4M | 3.7M | 2.6M | 2.9M | 3.9M | |
Other Stockholder Equity | 1.1B | 1.2B | 1.2B | 73.5M | 84.5M | 80.3M | |
Total Liab | 163.3M | 165.1M | 167.6M | 188.8M | 217.1M | 163.4M | |
Property Plant And Equipment Gross | 12.1M | 28.3M | 28.5M | 24.1M | 27.7M | 29.1M | |
Total Current Assets | 148.2M | 69.8M | 81.7M | 86.5M | 99.4M | 116.5M | |
Accumulated Other Comprehensive Income | 65.8M | 70.7M | 73.5M | 78.3M | 90.0M | 46.0M | |
Intangible Assets | 446.1M | 444.2M | 442.7M | 441.3M | 507.5M | 352.8M | |
Non Current Liabilities Total | 69.0M | 113.7M | 125.6M | 115.6M | 104.0M | 128.2M | |
Short Term Debt | 56.0M | 8.2M | 10.0M | 16.5M | 19.0M | 25.5M | |
Non Currrent Assets Other | 1.7M | 1.7M | 481K | 2.1M | 1.9M | 2.0M | |
Inventory | (4.1M) | (1.6M) | (252K) | (4.3M) | (3.9M) | (3.7M) | |
Common Stock | 1.2B | 1.2B | 1.2B | 1.3B | 1.5B | 1.0B | |
Other Liab | 30.8M | 19.5M | 15.0M | 19.1M | 17.2M | 16.3M | |
Net Tangible Assets | (32.3M) | 851K | (81.6M) | (75.3M) | (86.6M) | (91.0M) | |
Other Assets | 3.3M | 1.7M | 1.9M | 2.3M | 2.1M | 2.0M | |
Property Plant Equipment | 10.3M | 12.1M | 10.0M | 6.5M | 7.5M | 6.0M | |
Long Term Investments | 2.1M | 1.8M | 1.8M | 1.0M | 912.6K | 1.6M | |
Net Invested Capital | 675.6M | 593.7M | 610.6M | 594.7M | 683.9M | 659.7M | |
Net Working Capital | 54.0M | 18.5M | 39.7M | 13.2M | 11.9M | 11.3M | |
Short Long Term Debt Total | 105.5M | 106.9M | 116.5M | 118.9M | 136.8M | 108.1M | |
Long Term Debt | 41.0M | 91.6M | 102.8M | 100.5M | 115.6M | 81.7M | |
Short Long Term Debt | 53.2M | 5.0M | 6.0M | 13.9M | 12.5M | 21.0M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.